Immunoglobulin Fab Fragments < Immunoglobulin G < Immunoglobulin Heavy Chains

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]

Ident.	Authors (with country if any)	Title
000081 (2019)	Xavier Saelens	The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines.
000430 (2017)	Tülin Morç L [États-Unis] ; Brett L. Hurst [États-Unis] ; E Bart Tarbet [États-Unis]	Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
000473 (2016)	Gi-Ja Lee [Corée du Sud] ; Fu-Shi Quan [Corée du Sud]	Protection induced by early stage vaccination with pandemic influenza virus-like particles.
000517 (2016)	Bruce D. Wines [Australie] ; Hillary A. Vanderven [Australie] ; Sandra E. Esparon [Australie] ; Anne B. Kristensen [Australie] ; Stephen J. Kent [Australie] ; P Mark Hogarth [Australie]	Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.
000529 (2016)	Gudrun S. Freidl [Pays-Bas] ; Henk-Jan Van Den Ham [Pays-Bas] ; Maciej F. Boni [Viêt Nam] ; Erwin De Bruin [Pays-Bas] ; Marion P G. Koopmans [Pays-Bas]	Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic.
000635 (2015)	Kristin G-I Mohn [Norvège] ; Rebecca Jane Cox [Norvège] ; Gro Tunheim [Norvège] ; Jan Erik Berdal [Norvège] ; Anna Germundsson Hauge [Norvège] ; Sne Jul-Larsen [Norvège] ; Bjoern Peters [États-Unis] ; Fredrik Oftung [Norvège] ; Christine Monceyron Jonassen [Norvège] ; Siri Mjaaland [Norvège]	Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.
000683 (2015)	Syed Sohail Ahmed [Italie] ; Wayne Volkmuth [États-Unis] ; José Duca [États-Unis] ; Lorenzo Corti [Italie] ; Michele Pallaoro [Italie] ; Alfredo Pezzicoli [Italie] ; Anette Karle [Suisse] ; Fabio Rigat [Italie] ; Rino Rappuoli [Italie] ; Vas Narasimhan [États-Unis] ; Ilkka Julkunen [Finlande] ; Arja Vuorela [Finlande] ; Outi Vaarala [Finlande] ; Hanna Nohynek [Finlande] ; Franco Laghi Pasini [Italie] ; Emanuele Montomoli [Italie] ; Claudia Trombetta [Italie] ; Christopher M. Adams [États-Unis] ; Jonathan Rothbard [États-Unis] ; Lawrence Steinman [États-Unis]	Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.
000688 (2015)	Yoshikazu Honda-Okubo [Australie] ; Chun Hao Ong [Australie] ; Nikolai Petrovsky [Australie]	Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.
000743 (2014)	Jyothi K. Mallajosyula [États-Unis] ; Ernie Hiatt [États-Unis] ; Steve Hume [États-Unis] ; Ashley Johnson [États-Unis] ; Trushar Jeevan [États-Unis] ; Rachel Chikwamba [Afrique du Sud] ; Gregory P. Pogue [États-Unis] ; Barry Bratcher [États-Unis] ; Hugh Haydon [États-Unis] ; Richard J. Webby [États-Unis] ; Alison A. Mccormick [États-Unis]	Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.
000781 (2014)	Bao-Zhong Wang [États-Unis] ; Harvinder S. Gill [États-Unis] ; Cheng He [République populaire de Chine] ; Changbo Ou [République populaire de Chine] ; Li Wang [États-Unis] ; Ying-Chun Wang [États-Unis] ; Hao Feng [États-Unis] ; Han Zhang [États-Unis] ; Mark R. Prausnitz [États-Unis] ; Richard W. Compans [États-Unis]	Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.
000797 (2014)	Zhu-Nan Li ; Seh-Ching Lin [États-Unis] ; Paul J. Carney [États-Unis] ; Ji Li [États-Unis] ; Feng Liu [États-Unis] ; Xiuhua Lu [États-Unis] ; Merry Liu [États-Unis] ; James Stevens [États-Unis] ; Min Levine [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Kathy Hancock [États-Unis]	IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
000887 (2013)	Karen K. Yam [Canada] ; Jyotsana Gupta ; Angela Brewer ; David W. Scheifele ; Scott Halperin ; Brian J. Ward	Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.
000940 (2013)	Xiaoqing Liu ; Yuan Liu ; Yanjun Zhang ; Zhihui Chen ; Ziwei Tang ; Qingqiang Xu ; Yue Wang ; Ping Zhao ; Zhongtian Qi	Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population.
000C35 (2012)	Yeu-Chun Kim [Corée du Sud] ; Jae-Min Song ; Aleksandr S. Lipatov ; Seong-O Choi ; Jeong Woo Lee ; Ruben O. Donis ; Richard W. Compans ; Sang-Moo Kang ; Mark R. Prausnitz	Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
000D05 (2012)	Teresa M. Cabral [Canada] ; Yohannes Berhane ; Lisa Schmidt ; Dobryan M. Tracz ; Kate Hole ; Marsha Leith ; Cindi R. Corbett	Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
000D65 (2011)	Kai Li [République populaire de Chine] ; Jing Luo ; Chengmin Wang ; Hongxuan He	α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice.
001108 (2010)	Fu-Shi Quan [États-Unis] ; Aswani Vunnava ; Richard W. Compans ; Sang-Moo Kang	Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
001495 (2009)	Nayana Prabhu [Singapour] ; Mookkan Prabakaran ; Qian Hongliang ; Fang He ; Hui-Ting Ho ; Jia Qiang ; Michael Goutama ; Angeline Pei-Chiew Lim ; Brendon J. Hanson ; Jimmy Kwang	Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
001569 (2009)	Lucy A. Perrone [États-Unis] ; Attiya Ahmad ; Vic Veguilla ; Xiuhua Lu ; Gale Smith ; Jacqueline M. Katz ; Peter Pushko ; Terrence M. Tumpey	Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
001583 (2009)	J J C. De Vries [Pays-Bas] ; L. Bungener ; W. Ter Veer ; L. Van Alphen ; P. Van Der Ley ; J. Wilschut ; A. Huckriede	Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
001659 (2009)	Wagner Quintilio [Brésil] ; Flavia S. Kubrusly ; Dmitri Iourtov ; Cosue Miyaki ; Maria Aparecida Sakauchi ; Fernanda Lúcio ; Sandra De Cássia Dias ; Celia S. Takata ; Eliane N. Miyaji ; Hisako G. Higashi ; Luciana C C. Leite ; Isaias Raw	Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Immunoglobulin G" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Immunoglobulin G" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Immunoglobulin G
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021